An evidence-based set of pediatric mental healthcare quality measures were tested in two community hospitals and three children’s hospitals. Eligible patients ranged from ages 5 to 19 and were diagnosed with psychosis, suicidality or substance use between January 2012 and December 2013. Eight hundred and seventeen records were abstracted with primary diagnoses of suicidality (446), psychosis (321) and substance use (50).
Four insights from the research:
1. Among patients with suicidality, male patients and African-American patients were less likely to have documentation from caregivers verifying they provided counseling on keeping firearms or other potentially lethal devices away.
2. Among admitted suicidal patients, 27 percent had documentation of communication with an outside provider, with variation across hospitals.
3. The study found low overall performance on screening for comorbid substance abuse in ED patients diagnosed with psychosis.
4. “These new pediatric mental health care quality measures were used to identify sex and race disparities and substantial hospital variation,” the researchers concluded. “These measures may be useful for assessing and improving hospital-based pediatric mental healthcare quality.”
More articles on clinical leadership and infection control:
Chipotle to offer nurses BOGO meals June 5
Houston hospital suspends heart transplants after recent deaths: 7 things to know
How pharmacists are slashing readmission rates at a Philadelphia hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
